Biomarkers in TAA-the holy grail

Guido H W van Bogerijen, Jip L. Tolenaar, Viviana Grassi, Chiara Lomazzi, Sara Segreti, Vincenzo Rampoldi, John A. Elefteriades, Santi Trimarchi

Research output: Contribution to journalArticlepeer-review


Thoracic aortic aneurysm (TAA) is a silent disease, often discovered at a time point that dramatic complications, as rupture and dissection, occur. For the detection of asymptomatic TAA and prevention of such complications, it is essential to have an adequate screening tool. Until now, routine laboratory blood tests have played only a minor role in the screening, diagnosis, tracking and prediction of the natural history of TAAs. However, the knowledge about biomarkers is rapidly expanding in the cardiovascular field, and there are several potential biomarkers that might be implemented into TAA clinical practice in the near future. The most important and promising markers for TAA will be discussed in this overview.

Original languageEnglish
Pages (from-to)109-115
Number of pages7
JournalProgress in Cardiovascular Diseases
Issue number1
Publication statusPublished - Jul 2013


  • Biomarkers
  • TAA
  • Thoracic aortic aneurysm

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Biomarkers in TAA-the holy grail'. Together they form a unique fingerprint.

Cite this